Midterm outcomes in patients with intermediate‐sized hepatocellular carcinoma
Authors:
Open Access
- 29 November 2010
- Vol. 116 (23) , 5452-5460
Abstract
BACKGROUND: To improve the efficacy of radiofrequency ablation (RFA) for the treatment of intermediate‐sized hepatocellular carcinomas (HCCs), the authors compared RFA combined with transcatheter arterial chemoembolization (TACE) to RFA alone.METHODS: The authors randomly assigned 37 patients with solitary HCCs (diameter, 3.1‐5.0 cm in the greatest dimension) to 2 groups: the TACE‐RFA group, in which the patients received TACE followed by RFA on the same day, and the RFA group, in which the patients received only RFA.RESULTS: Technical success was achieved after 1.4 ± 0.5 RFA sessions in the RFA group and after 1.1 ± 0.2 RFA sessions in the TACE‐RFA group (P < .01). The mean diameters of the longer and shorter axes of the RFA‐induced ablated areas were 50 ± 8.0 mm and 41 ± 7.1 mm, respectively, in the RFA group and 58 ± 13.2 mm and 50 ± 11.3 mm, respectively, in the TACE‐RFA group; the mean diameters of the shorter axes were significantly different (P = .012). The rates of local tumor progression at the end of the third year in the RFA and TACE‐RFA groups were 39% and 6%, respectively (P = .012). The 3‐year survival rates of the patients in the RFA and TACE‐RFA groups were 80% and 93%, respectively (P = .369).CONCLUSIONS: In patients with intermediate‐sized HCCs, RFA combined with TACE is more effective than RFA alone for extending the ablated area in fewer treatment sessions and for decreasing the local tumor progression rate. Cancer 2010. © 2010 American Cancer Society.Keywords
This publication has 40 references indexed in Scilit:
- Randomized controlled trial for the efficacy of hepatic arterial occlusion during radiofrequency ablation for small hepatocellular carcinoma – direct ablative effects and a long‐term outcomeLiver International, 2007
- Prediction of recurrence of hepatocellular carcinoma after curative ablation using three tumor markersHepatology, 2006
- Management of Hepatocellular Carcinoma *Hepatology, 2005
- Radiofrequency ablation in a pig liver model: effect of transcatheter arterial embolization on coagulation diameter and histologic characteristicsHepatology Research, 2002
- Treatment of hepatocellular carcinoma with radiofrequency ablation: Radiologic-histologic correlation during follow-up periodsHepatology, 2002
- Percutaneous Radiofrequency Ablation of Hepatic Tumors During Temporary Venous OcclusionAmerican Journal of Roentgenology, 2002
- Percutaneous Radiofrequency Thermal Ablation Combined with Transcatheter Arterial Embolization in the Treatment of Large Hepatocellular CarcinomaUltraschall in der Medizin - European Journal of Ultrasound, 1999
- Patterns of Recurrence After Initial Treatment in Patients With Small Hepatocellular CarcinomaHepatology, 1997
- Percutaneous ethanol injection for the treatment of small hepatocellular carcinoma. Study of 95 patientsJournal of Gastroenterology and Hepatology, 1990
- Fucosylation of serum α-fetoprotein in patients with primary hepatocellular carcinomaBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1985